Abivax
Paris, FR · Founded 2013 · 7 known investors
Find your way into Abivax
Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
Founders & leadership
MD
Marc de Garidelin𝕏CEOHe previously led CinCor Pharma, AZTherapies and Corvidia Therapeutics as chief executive, and spent years at Ipsen, serving as Chairman and CEO from 2010 to 2016 and as Chairman thereafter. He joined Abivax in 2023, initially as CEO and interim chairman.
Investors · 7
Competitors · 6
by search overlap
Dynavax NASDAQ: DVAX www.dynavax.com40 shared keywordsDynavax is a commercial-stage biopharmaceutical company that develops and commercializes vaccines against infectious diseases using its adjuvant technology. Its products target immunization and infectious disease prevention.
Robinhood37 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha37 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Vaccinex35 shared keywordsVaccinex is a clinical-stage biotechnology company developing pepinemab (VX15/2503), a humanized monoclonal antibody that blocks SEMA4D signaling, in trials for neurological disorders such as Huntington's and Alzheimer's disease and for solid tumors including breast cancer, melanoma, non-small cell lung cancer and head and neck cancer. It also offers a fusion protein and ActivMab antibody discovery technology for incorporating membrane proteins such as GPCRs and ion channels into poxviruses for antibody selection.
StockTwits34 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Imvax34 shared keywordsImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies competing with Abivax for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Abivax do?
- Abivax develops obefazimod, an orally administered small molecule drug candidate with a novel mechanism of action targeting microRNA biology to treat chronic inflammatory diseases including ulcerative colitis and Crohn's disease.
- Who are Abivax's investors?
- Abivax's investors include Andera Partners, Claret Capital Partners, Medicxi, Samsara BioCapital, Sofinnova Partners, Truffle Capital, Morgan Stanley.
- Where is Abivax headquartered?
- Abivax is headquartered in Paris, FR.